These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32512653)

  • 1. Hereditary Haemorrhagic Telangiectasia (HHT) Marked by ACVRL1C1120T Variant Displays Hypopigmented Naevi and Frequent Bleeding Episodes if CYP2C9 Co-Mutated: Clinical Notes & Rationale of Patient Registry.
    Minarik L; Vargova K; Dusilkova N; Kulvait V; Jonasova A; Kodet O; Stopka T
    Folia Biol (Praha); 2020; 66(1):1-6. PubMed ID: 32512653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic children with hereditary hemorrhagic telangiectasia: a pediatric center experience.
    Mei-Zahav M; Letarte M; Faughnan ME; Abdalla SA; Cymerman U; MacLusky IB
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):596-601. PubMed ID: 16754821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia.
    Kjeldsen AD; Møller TR; Brusgaard K; Vase P; Andersen PE
    J Intern Med; 2005 Oct; 258(4):349-55. PubMed ID: 16164574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital Clubbing in Hereditary Hemorrhagic Telangiectasia/Juvenile Polyposis Syndrome.
    Mrzljak A; Popić J; Ožanić Bulić S
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):56-57. PubMed ID: 34477067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
    Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
    BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and genetic diagnosis in a hereditary hemorrhagic telangiectasia family].
    Yi Y; Liu X; Wu B; Liu J; Ge S; Shi X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1017-1022. PubMed ID: 28989145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel ENG gene mutation (c.1550_1551dupTG, p.S518*) in a Chinese family with hereditary hemorrhagic telangiectasia.
    Chen F; Yang M; Wen Z; Yu C
    Med Clin (Barc); 2021 Dec; 157(11):537-541. PubMed ID: 34728086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function.
    Lyster AL; Biørn SH; Kjeldsen AD; Nielsen C; Lange B; Fialla AD; Vinholt PJ
    Orphanet J Rare Dis; 2023 Nov; 18(1):354. PubMed ID: 37964294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
    Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
    Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
    Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
    Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.
    Hammill AM; Wusik K; Kasthuri RS
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):469-477. PubMed ID: 34889398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
    Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JP-HHT phenotype in Danish patients with SMAD4 mutations.
    Jelsig AM; Tørring PM; Kjeldsen AD; Qvist N; Bojesen A; Jensen UB; Andersen MK; Gerdes AM; Brusgaard K; Ousager LB
    Clin Genet; 2016 Jul; 90(1):55-62. PubMed ID: 26572829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ
    J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
    Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
    Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.